Algirdas Baranauskas
Lithuanian University of Health Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Algirdas Baranauskas.
Pharmaceutical Development and Technology | 2017
Juste Baranauskaite; Liudas Ivanauskas; Ruta Masteikova; Dalia M. Kopustinskiene; Algirdas Baranauskas; Jurga Bernatoniene
Abstract The aim of this study was optimization of spray-drying process conditions for microencapsulation of Turkish oregano extract. Different concentrations of maltodextrin and gum arabic as encapsulating agents (wall material) as well as influence of selected processing variables were evaluated. The optimal conditions were maintained on the basis of the load of main bioactive compounds – ursolic, rosmarinic acids and carvacrol – in prepared microparticles after comparison of all significant response variables using desirability function. Physicomechanical properties of powders such as flowability, wettability, solubility, moisture content as well as product yield, encapsulation efficiency (EE), density, morphology and size distribution of prepared microparticles have been determined. The results demonstrated that the optimal conditions for spray-drying mixture consisted of two parts of wall material solution and one part of ethanolic oregano extract when the feed flow rate was 40 mL/min and air inlet temperature –170 °C. Optimal concentration of wall materials in solution was 20% while the ratio of maltodextrin and gum arabic was 8.74:1.26.
DARU | 2012
Aurima Stankuniene; Mindaugas Stankunas; Joaquim Soares; Mark Avery; M. Gabriella Melchiorre; Francisco Torres-González; Raimondas Radziunas; Algirdas Baranauskas; Jutta Lindert
BackgroundThe use of medicines by elderly people is a growing area of concern in social pharmacy. A significant proportion of older people do not follow the recommendations from physicians and refrain from buying prescribed medications. The aim of this study is to evaluate associations between self-rated health, somatic complaints and refraining from buying prescribed medications by elderly people.FindingsData was collected in a cross-sectional study in 2009. We received 624 completed questionnaires (response rate – 48.9%) from persons aged 60–84 years living in Kaunas (Lithuania). Somatic complaints were measured with the 24 item version of the Giessen Complaint List (GBB-24). Logistic regression (Enter model) was used for evaluation of the associations between refraining from buying medications and somatic complaints. These associations were measured using odds ratio (OR) and calculating the 95% confidence interval (CI).The mean scores in total for the GBB scale and sub-scales (exhaustion, gastrointestinal and cardiovascular) were lowest among respondents who did not refrain from buying prescribed medications (means for GBB-24 scale: 21.04 vs. 24.82; p=0.001). Logistic regression suggests that somatic complaints were associated with a increased risk of refraining from buying prescribed medications (OR=1.35, 95% CI=1.15-1.60).ConclusionsSomatic complaints were significantly associated with the decision to refrain from buying prescribed medications.
BioMed Research International | 2017
Juste Baranauskaite; Asta Kubiliene; Mindaugas Marksa; Vilma Petrikaite; Konradas Vitkevičius; Algirdas Baranauskas; Jurga Bernatoniene
The aim of this study was to evaluate concentration-dependent antioxidant and anticancer activities of CA and RA in ethanol extracts of three different Oregano species (Origanum onites L., Origanum vulgare L., and Origanum vulgare ssp. hirtum). The study revealed the highest RA antioxidant activity in O. vulgare ssp. hirtum (9550 ± 95 mmol/g) and the lowest in O. vulgare L. (2605 ± 52 mmol/g) (p < 0.05). The highest CA amount was present in O. onites L., which was 1.8 and 4.7 times higher (p < 0.05) than in O. vulgare ssp. hirtum and O. vulgare L., respectively. The anticancer activity was evaluated on human glioblastoma (U87) and triple-negative breast cancer (MDA-MB231) cell lines in vitro. RA anticancer activity was negligible. CA and the extracts were about 1.5–2 times more active against MDA-MB231 cell line (p < 0.05) compared to U87 cell line. The anticancer activities of three tested extracts were similar against U87 cell line (p > 0.05) but they had different activities against MDA-MB231 cell line.
Central European Journal of Medicine | 2013
Aurima Stankuniene; Mindaugas Stankunas; Mark Avery; Raimondas Radziunas; Joaquim Soares; M. Gabriella Melchiorre; Francisco Torres-González; Algirdas Baranauskas; Jutta Lindert
AimTo evaluate the associations between socio-economical factors and the use of medications in the elderly.MethodsThe data was collected in a cross-sectional study in 2009. We received 624 completed questionnaires (response rate — 48.9%) from elderly people aged 60–84 years living in Kaunas (Lithuania). For an evaluation of the impact of explanatory variables on the analyzed events (binary dependent variable), an Enter model of logistic regression was used.ResultsOur findings suggest that 50.8% (n=317) of respondents used at least one drug daily. 18.3% (n=114) of respondents indicated that they use medications regularly, but not on a day-by-day basis. One quarter (25.6%; n=160) used medication only on an “at need” basis. Only 5.3% (n=33) of older persons did not use any medications at all. Logistic regression showed that being male (OR=0.67; 95%CI:0.45–0.98) was associated with using medications “regularly + daily.” For the use of “daily” medications, older age (OR=1.33; 95%CI:1.15–1.53) was associated with using medications daily. An opposite association was observed for respondents having no paid work (OR=0.48; 95%CI:0.26–0.82).ConclusionsOur study suggests that more than half of older persons in Lithuania use medications every day. Use was associated with socioeconomic factors (gender, age, and employment status).
Medicina-lithuania | 2007
Liudas Ivanauskas; Valdas Jakštas; Jolita Radušienė; Audronis Lukošius; Algirdas Baranauskas
Medicina-lithuania | 2005
Algirdas Baranauskas; Bernatoniene J; Radziūnas R; Bernatonis D
Colloids and Surfaces A: Physicochemical and Engineering Aspects | 2018
Juste Baranauskaite; Dalia M. Kopustinskiene; Ruta Masteikova; Jan Gajdziok; Algirdas Baranauskas; Jurga Bernatoniene
Archive | 2005
Algirdas Baranauskas; Jurga Bernatonienė; Raimondas Radžiūnas; Domininkas Bernatonis
BioMed Research International | 2018
Juste Baranauskaite; Gulengul Duman; Gulcan Corapcioglu; Algirdas Baranauskas; Alpay Taralp; Liudas Ivanauskas; Jurga Bernatoniene
Archive | 2017
Algirdas Baranauskas; Raimondas Radžiūnas; Vaidas Skyrius; Jonas Grincevičius; Rita Mikalauskienė; Aurima Stankūnienė